Compare TKNO & MITT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TKNO | MITT |
|---|---|---|
| Founded | 1996 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.1M | 245.5M |
| IPO Year | 2021 | N/A |
| Metric | TKNO | MITT |
|---|---|---|
| Price | $5.59 | $7.04 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $9.25 |
| AVG Volume (30 Days) | 115.6K | ★ 135.1K |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 11.96% |
| EPS Growth | ★ 43.86 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $40,520,000.00 | N/A |
| Revenue This Year | $8.27 | $3.48 |
| Revenue Next Year | $13.13 | $5.06 |
| P/E Ratio | ★ N/A | $9.34 |
| Revenue Growth | ★ 7.35 | N/A |
| 52 Week Low | $1.91 | $6.91 |
| 52 Week High | $6.68 | $9.27 |
| Indicator | TKNO | MITT |
|---|---|---|
| Relative Strength Index (RSI) | 59.19 | 32.56 |
| Support Level | $4.87 | N/A |
| Resistance Level | $5.88 | $7.97 |
| Average True Range (ATR) | 0.37 | 0.16 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 74.77 | 10.80 |
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.
TPG Mortgage Investment Trust Inc is a real estate investment trust (REIT). It focuses on investing in a diversified risk-adjusted portfolio of residential mortgage-related assets in the U.S. mortgage market. Its objective is to provide attractive risk-adjusted returns to its stockholders over the long term through dividends and capital appreciation. The company focuses on its investment activities on acquiring and securitizing newly-originated residential mortgage loans within the non-agency segment of the housing market.